IGC Pharma, Inc. (then India Globalization Capital, Inc.) — Form 10-K Summary
Reporting period: Fiscal year ended March 31, 2012; this is an annual report, not a standalone 2011 fourth-quarter filing. The company operated infrastructure-materials, mining and construction businesses in India and China. It acquired HK Ironman on December 30, 2011, gaining a 95% interest in PRC Ironman.
Financial performance and position
| Metric | FY 2012 | FY 2011, restated |
|---|---|---|
| Revenue | $4.20 million | $4.07 million |
| Cost of revenue | $4.82 million | $3.91 million |
| Operating loss | $7.51 million | $15.89 million |
| Net loss attributable to common shareholders | $7.75 million; $0.27 per share | $20.24 million; $1.34 per share |
| Cash used in operating activities | $5.02 million | $2.63 million |
| Cash and cash equivalents at year-end | $0.56 million | $1.58 million |
| Total assets / total liabilities | $25.26 million / $9.44 million | $18.16 million / $7.79 million |
Cost of revenue exceeded revenue in FY 2012, producing negative gross profit before depreciation. Cost of revenue rose 23% while revenue grew about 3%; management cited higher input costs and an Ironman inventory revaluation. SG&A fell to $4.70 million from $7.28 million, mainly because FY 2011 included substantial receivable and bad-debt provisions; FY 2012 also included Ironman acquisition expenses. FY 2012 included a $1.19 million impairment of the Sricon investment; FY 2011 included $5.79 million of goodwill impairment and $2.18 million of investment impairment.
At March 31, 2012, current assets were $5.22 million and current liabilities $4.50 million. Notes payable were $1.80 million, short-term borrowings $0.21 million, and loans from others $0.22 million. Non-current liabilities of $4.23 million included acquisition-related incentive compensation provisions. Operating cash outflow increased year over year. The company reported $4.67 million of investing cash inflow, including acquisition-related deposits and release of restricted cash, and $0.63 million of financing cash outflow.
Material changes versus the prior year
- The Ironman acquisition added Chinese beneficiation assets, goodwill and intangible assets; the acquired business contributed only from the acquisition date to year-end. The Chinese plants were shut during January–March 2012 while integration, reporting and compliance processes were addressed.
- Indian iron-ore mines remained closed through FY 2012 amid government restrictions and investigations. IGC-IMT revenue was principally domestic ore trading; the company reported no revenue from PRC Ironman in the period after acquisition.
- Debt and payables were reduced during the year, while outstanding common shares increased substantially, to 60.06 million at March 31, 2012 from 14.89 million a year earlier, primarily reflecting the Ironman share consideration and other share issuances.
- Management’s results table and narrative contain some inconsistent figures: the audited statements report revenue of $4.20 million and operating loss of $7.51 million; the MD&A narrative gives revenue as approximately $4.12 million and a different operating-loss figure. The audited statements are used above.
Outlook, risks and unusual items
Management expected to complete Ironman integration and reopen its plants in FY 2013’s second quarter, and anticipated positive operating cash flow in FY 2013. It also expected Indian mines to reopen, potentially by year-end 2012, enabling exports to China. These are forward-looking expectations, not reported outcomes. Management said available cash, anticipated operating cash flow and potential claim proceeds could sustain the company for 12 months, but would not fund growth.
- Approximately $2.5 million related to a TBL arbitration award was deposited with the Delhi High Court. Access required arranging a letter of credit; timing and realization were uncertain. The company also disclosed about $1.64 million in receivables and claims.
- After year-end, on April 5, 2012, IGC settled a $2.23 million note with 4,426,304 newly issued shares. The noteholder claimed entitlement to 5 million shares; the company disputed the claim, and no legal action had been filed as of the report.
- Ironman acquisition consideration was reported as $13.10 million, including stock and contingent payments. A separate $1 million payment tied to post-closing conditions was not made because the conditions were not met. Additional earn-outs depended on specified earnings-growth targets.
- Subsequent to year-end, IGC agreed to acquire Chinese land for $4.4 million and to exchange its 22% Sricon interest for approximately five acres of land in Nagpur.
- Risks include low cash reserves and continuing operating cash burn; iron-ore price, weather and supply volatility; Indian export restrictions and mine closures; concentrated customers; currency controls and repatriation delays; reliance on licenses and government contracts; dilution and financing access; and challenges integrating Ironman. The company disclosed limited insurance for Chinese operations and no flood or other property insurance for mining assets.
- Management concluded disclosure controls were ineffective and identified a material weakness in internal control over financial reporting, including insufficient experienced personnel for SEC and U.S. GAAP reporting. Prior financial statements had been restated. The independent auditor gave an unqualified opinion on the FY 2012 and FY 2011 financial statements; the auditor did not attest to internal-control effectiveness.
Investor verification priorities
- Reconcile the inconsistent MD&A figures with the audited statements and review the basis and final allocation of Ironman’s purchase price, intangible assets and contingent consideration.
- Confirm whether Ironman’s plants and Indian mines restarted as projected, and whether operations generated the cash flow management anticipated.
- Verify access to the High Court award funds, collection of aged government receivables and claims, and progress on the Sricon settlement and land exchange.
- Track the disputed share settlement, remaining debt and acquisition-related liabilities, as well as dilution from shares, options and warrants.
- Assess remediation of the disclosed material weakness and the reliability of financial reporting across India and China.